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YAP and TAZ in epithelial stem cells:
A sensor for cell polarity, mechanical
forces and tissue damage
Ahmed Elbediwy, Zoe I. Vincent-Mistiaen and Barry J. Thompson
The YAP/TAZ family of transcriptional co-activators
drives cell proliferation in epithelial tissues and cancers.
Yet, how YAP and TAZ are physiologically regulated
remains unclear. Here we review recent reports that YAP
and TAZ act primarily as sensors of epithelial cell polarity,
being inhibited when cells differentiate an apical mem-
brane domain, and being activated when cells contact the
extracellular matrix via their basal membrane domain.
Apical signalling occurs via the canonical Crumbs/CRB-
Hippo/MST-Warts/LATS kinase cascade to phosphory-
late and inhibit YAP/TAZ. Basal signalling occurs via
Integrins and Src family kinases to phosphorylate and
activate YAP/TAZ. Thus, YAP/TAZ is localised to the
nucleus in basal stem/progenitor cells and cytoplasm in
differentiated squamous cells or columnar cells. In
addition, other signals such as mechanical forces, tissue
damage and possibly receptor tyrosine kinases (RTKs)
can influence MST-LATS or Src family kinase activity to
modulate YAP/TAZ activity.
Keywords:.epithelial polarity; Hippo pathway; mechanosensing;
mechanotransduction; TAZ; wound healing; YAP
Introduction
Animal tissues, from Drosophila to humans, tend to harbour
a population of stem cells that is responsible for maintain-
ing the tissue through cell proliferation and differentiation
of daughter cells [1–5]. Stem cells can proliferate to maintain
normal tissue homeostasis, but also increase their prolifer-
ation in response to mechanical stretching of the tissue
or to tissue damage and consequent inflammation. For
example, the normal growth of the skin from newborn to
adulthood occurs through stretching of the tissue, which
promotes proliferation of basal layer stem/progenitor
cells. In addition, wounding or infection of the skin also
triggers a proliferative response of basal layer cells to
replace the damaged skin with new cells. How these events
are orchestrated at the molecular level, and whether they
become deregulated in human epithelial cancers, is still
poorly understood.
Recent discoveries from Drosophila genetics identified the
YAP/TAZ family of transcriptional co-activators (the sole
Drosophila homologue is called Yorkie) as being essential
regulators of cell proliferation during development and in
adult stem cells of the intestine [6–9].Drosophila Yorkie drives
transcription of pro-proliferative target genes through inter-
action with the TEAD-family DNA binding transcription factor
Scalloped, as well as additional co-factors MASK, WBP2 and
Brahma [10–16]. Importantly, Yorkie is regulated by the cell
polarity machinery in epithelial cells, being activated upon
loss of the apical polarity determinant Crumbs, or loss of the
planar polarity determinant Fat [17–22]. There is also evidence
for Yorkie acting as a sensor of mechanical forces during
development, where it promotes cell proliferation in response
to epithelial stretch forces acting on the cytoskeleton [23, 24].
Furthermore, Yorkie activity is induced upon tissue damage
to promote intestinal stem cell proliferation and tissue
repair [7–10].
Here we review the molecular mechanisms responsible
for regulation of Yorkie by cell polarity, force and damage
in Drosophila. We then examine the regulation of YAP and
TAZ in different mammalian epithelial tissues in vivo,
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which points to the existence of fundamentally conserved
mechanisms between Drosophila and mammals. We also
examine the regulation of YAP and TAZ during human
epithelial cancerprogression,wheredisruptionof cell polarity,
invasive migration, as well as damage and inflammation
all appear to promote the action of YAP and TAZ in the
nucleus. Our observations outline a unifying regulatory logic
controlling YAP/TAZ co-activators (summarised in Figs. 1–4)
and also suggest avenues for therapeutic intervention in
inflammation and cancer. Finally, we are critical of results
in cell culture that are unsupported by related findings
in vivo.
Yorkie as polarity-sensor, mechano-sensor and
damage-sensor in vivo
Apical Crumbs signalling represses Yorkie
The apical polarity determinant Crumbs was long thought to
be essential for cells to maintain an apical domain, so it
was surprising when loss of Crumbs was discovered to cause
tissue overgrowth in Drosophila adult tissues, such as the
wing or eye [17, 18]. The overgrown crumbs-mutant tissues
were found to have normal apical-basal polarity, due to the
presence of the redundant factor Bazooka/Par3, and also
exhibited upregulation of Yorkie-target genes [17,
18, 24–27]. Crumbs was found to bind directly to
Expanded, via its FERM-binding domain, and
thus to activate the canonical Hippo-Warts kinase
cascade to repress Yorkie activity [17, 18, 28, 29].
Recent work has confirmed that phosphorylated
Warts kinase can be detected precisely where
Crumbs is localised in the developing wing [30].
Thus, Crumbs is not only a key apical domain
determinant, but also has a second function
in activating Hippo signalling to repress Yorkie
(Fig. 2).
Junctional Ft-Ds cadherins and E-cadherin
associated signals regulate Yorkie
The planar polarity determinants Fat (Ft) and
Dachsous (Ds) are atypical cadherins that localise
to adherens junctions with E-cadherin, but in an
asymmetric fashion [31, 32] (Fig. 3). Ft-Ds
interactions are well known to cause the planar
polarisation of the atypical myosin Dachs (D),
which acts as an F-actin motor protein to increase
tension at adherens junctions to promote tissue
elongation via biasing the orientation of cell
divisions and cell-cell rearrangements [33–36]
(Fig. 3). Interestingly, loss of Fat produces not
only a failure of tissue elongation, but also tissue
overgrowth due to activation of Yorkie-target
genes [19–22, 34, 37] (Fig. 3). This activation of
Yorkie-driven growth was found to depend strictly
on the accumulation of the Dachs myosin at
adherens junctions, and stabilisation of Dachs
at junctions is sufficient to drive tissue over-
growth [34, 38, 39]. Dachs appears to activate
Yorkie by antagonisingWarts [40], but the kinases
Minibrain (Mnb) and Riquiqui (Riq) also appear to
be involved and these can directly phosphorylate
Warts to repress its activity [41] (Fig. 3).
The F-actin associated proteins Ajuba, Zyxin,
and Src localise to adherens junctions and
promote activation of Yorkie-target genes and
tissue growth in the fly wing and eye [23, 42–48].
Since mammalian Src family kinases (Src, Fyn,
Yes) are known to phosphorylate and activate
mammalian homologues of Yorkie (YAP, or Yes-
associated protein, and TAZ) [49, 50], it is
plausible that Ajuba and Zyxin act to promote
Figure 1. Basal signals promote nuclear YAP localisation. A: In stratified
squamous epithelia, YAP/TAZ is nuclear in the basal cell layer which contacts
the basal lamina ECM via Integrins. Supra basal cells lose contact with the basal
lamina and thus experience reduced Integrin signalling and relocalisation of
YAP/TAZ to the cytoplasm. One exception are the extremely flattened terminally
differentiated cells, where YAP/TAZ can once again become nuclear, possibly
due to mechanical stretching. B: Integrin-Src-FAK signalling synergises with
EGFR-PI3K signalling to promote nuclear localisation of YAP. Src can directly
tyrosine-phosphorylate YAP, but may also act indirectly to inhibit Hippo
signalling, which inhibits YAP via serine/threonine phosphorylation to promote
cytoplasmic retention. PI3K induces PIP3 lipid formation, which may help
stabilise Integrin adhesions as well as inducing PDK1 and Akt activation. F-actin,
Rho and ROCK also generate actomyosin contractility to help stabilise Integrin
adhesions and thus may contribute to Src activation.
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Src activity at adherens junctions and thereby activate Yorkie
to drive tissue growth. Alternatively, Ajuba and Zyxin may
directly inhibit the Warts kinase, to reduce the inhibitory
phosphorylation of Yorkie by this kinase [23].
Basal Integrin signalling may activate Yorkie in
intestinal stem cells
Integrins are localised to the basal side of epithelial cells,
where they play a key role in cell adhesion to the extracellular
matrix [51]. In the Drosophila intestine, proliferation of stem
cells depends critically on Integrins and their intracellular
signal transducers such as Talin [52, 53]. How Integrin
signalling promotes stem cell proliferation remains unclear,
but both Src and Yorkie are of pivotal importance for
proliferation of these cells, suggesting a potential regulatory
connection [54]. Notably, intestinal stem cells lack an apical
domain, so are likely to have no Crumbs-Hippo-Warts
signalling and thus strongly active Yorkie that requires input
from basal Integrin-Src signalling to maintain stem cell
proliferation. Thus, Yorkie appears to act as a
sensor of cell polarity to promote proliferation in
stem cell populations.
Mechanical stretching activates Yorkie
In addition to acting as a sensor of cell polarity,
another possible physiological function for Yorkie
is as a mechanosensor – originally proposed in
mammalian cell culture for YAP/TAZ [55, 56]. In
the developing fly wing, peripheral epithelial cells
become circumferentially stretched by the morpho-
gen-driven growth of the central wing pouch, and
the stretched cells respond by proliferating more
to produce a near-uniform level of proliferation
across the entire tissue [57–61]. How these cells sense
mechanical forces was unclear, until it was revealed
that thedegree of stretchingcorrelatedwith increased
Yorkie-target gene activity [24].
One possible mechanosensor is Crumbs itself,
which binds to the apical Spectrin cytoskeleton – a
mechanically deformable network that is required for
Crumbs toactivateHipposignalling [24,62]. Stretching
of the apical domain of the cell correlates with a
decrease in the local density of Crumbs molecules,
which may then decrease the ability of Crumbs to
activate Hippo-Warts signalling and repress Yorkie
[24]. In support of this model, either forcing the
clustering of Crumbs with an extracellular ligand
(Crumbs itself expressed on neighbouring cells) or
increasing the local concentration of Hippo kinase can
strongly activate Hippo-Warts signalling and prevent
stretch-induced Yorkie activation [24]. Interestingly,
mechanical stretching of wing cells also leads to
increased recruitment of phosphorylated myosin-II
[60], and the same phenomenon occurs upon disrup-
tion of the apical Spectrin cytoskeleton [62], again
supporting a mechanosensory role for Spectrins.
Another possiblemechanosensor is the adherens
junction, whose associated proteins Ajuba and
Zyxin promote Yorkie activation in response to force upon
theactomyosin cytoskeleton [23, 44]. Itwill be interesting to test
whether the physiological stretch forces that occur during
development are sufficient to affect recruitment of Ajuba and
Zyxin and their ability to activate Src and/or inhibit Warts.
Presently, there is evidence that non-physiological reduction
of acto-myosin contractility at adherens junctions leads to
reduced Ajuba association [23], but this may simply be due to
the requirement for actomyosin in maintaining the adherens
junctions themselves. One plausible mechanism for mechano-
sensing isvia thealpha-cateninprotein,whichcanunfoldunder
force to reveal a Vinculin binding site, but further work is
necessary to test the role of Vinculin in regulation of Yorkie [63].
Tissue damage activates Yorkie
Another physiological function for Yorkie is sensing tissue
damage [64]. This role is best understood in the Drosophila
intestine, where damaging agents such as pathogenic bacteria
or chemical treatment with the insecticide Paraquat produce a
Figure 2. Apical signals inhibit nuclear YAP localisation. A: In columnar epithelia,
YAP/TAZ is cytoplasmic in differentiated cells with an apical domain and nuclear
in basal layer stem cells which lack an apical domain and contact the basal
lamina ECM via Integrins. B: Crumbs-Merlin-Kibra-Salvador-MST-LATS signalling
(the canonical Hippo pathway) leads to phosphorylation of YAP/TAZ and
retention in the cytoplasm (due to binding to 14-3-3 proteins) despite contact
with the ECM. Thus, strong apical Hippo signalling is able to overcome basal
Integrin signalling to maintain YAP/TAZ in the cytoplasm.
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massive stem cell proliferation response to regenerate the
tissue that depends upon Yorkie activity [7–9]. Interestingly,
Yorkie is required both in the stem cells for proliferation and in
the differentiated epithelial cells to sense damage. Yorkie
induces expression of JAK-STAT pathway ligands (Upds)
which signal to stem cells to further promote their prolifera-
tion [7–9]. Precisely, how Yorkie senses tissue damage
remains unclear, and this is a fundamentally important
question to answer to fully understand the physiological roles
of Yorkie in vivo. Recent work suggests that Yorkie inhibits the
infection-sensing Toll receptor – Dorsal/NF-kappaB pathway,
which in turn inhibits Yorkie activation [65]. Thus, tissue
damage sensing by Yorkie is likely to act in a parallel and
antagonistic manner to infection sens-
ing, perhaps to promote a sterile-
inflammation response rather than an
infection response. Further work is
necessary to explore this possible role
of Yorkie.
YAP/TAZ as polarity sensor
in vivo
Repression of YAP/TAZ by
apical signals
The mammalian Yorkie homologs
YAP and TAZ are clearly regulated by
the presence or absence of an apical
domain in mammalian epithelial cells
[49]. In columnar epithelia, YAP and
TAZ remain cytoplasmic, while in basal
layer epithelial stem cells that lack an
apical domain, YAP and TAZ localise to
the nucleus [49]. The organisation of the
bronchial epithelium is a good example
of this phenomenon, and it has been
shown that apical signalling requires
CRB3, a Crumbs homolog [66] (Fig. 2).
Stimulation of YAP/TAZ by basal
signals
Nuclear localisation of YAP and TAZ
also appears to be promoted by Integrin
signalling upon attachment of cells to
the basement membrane [49, 67, 68]. In
squamous epithelia, YAP and TAZ are
nuclear in basal layer stem/progenitor
cells but cytoplasmic inmost suprabasal
differentiating cells, despite the fact that
squamous epithelial cells never differen-
tiate an apical domain [49] (Fig. 1). This
finding suggests that loss of Integrin-
mediated contact with the basement
membrane extracellular matrix triggers
relocalisation of YAP and TAZ. The
organisation of the skin epithelium is a
goodexample of thismodeof regulation,
andregulationofYAPhasbeenshowntodependonIntegrin-Src
signalling in this tissue todriveproliferationofbasal layer stem/
progenitor cells [49, 67, 68] (Fig. 1). It will be interesting to
test whether Integrin-Src signalling regulates YAP/TAZ in other
tissues where Integrins, Src or YAP are known to drive cell
proliferation such as during liver regeneration [69, 70].
A role for signalling from adherens junctions?
Whether junctionally localised factors directly regulate YAP
and TAZ remains controversial. The atypical cadherins Fat
and Dachsous have multiple homologs in mammals, but
knockouts tend to affect tissue shape rather than tissue growth
Figure 3. Regulation of YAP by Crumbs and Cadherin signalling. A: Crumbs and E-cadherin
distribute around the entire circumference of the epithelial cell’s apical surface. In contrast,
Fat and Dachsous cadherins planar polarise to opposite ends of the cell. B: Crumbs signals
via canonical Merlin-Ex-Kibra-Sav-Hpo-Warts/LATS signalling to inhibit YAP by direct ser/thr
phosphorylation and cytoplasmic retention. E-cadherin recruits Ajuba/Zyxin proteins, which
may directly inhibit Warts/LATS kinases and Src family kinases, which tyrosine phosphorylate
and activate YAP. Dachsous recruits the Dachs myosin, which increases junctional tension,
as well as Riq and Mib, which may directly inhibit Warts/LATS kinases.
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in epithelia [71] (but they reveal a role in both neural and
nephron proliferation [72–75]). Furthermore, disruption of
adherens junctions in alpha-catenin knockout skin does not
lead to a reduction in YAP/TAZ activity or reduced cell
proliferation, but rather leads to overproliferation – suggesting
apossibly indirect activationofYAP/TAZvia increased Integrin-
Src signalling in alpha-catenin knockout skin [50, 76, 77].
Further work is necessary to investigate whether junctionally
associated Zyxin/TRIP6, Ajuba/WTIP or Src family members
contribute to YAP/TAZ activation in vivo, as they do for
Drosophila Yorkie (Fig. 3).
YAP/TAZ as mechano-sensor in vivo
YAP and TAZ were first proposed to be mechanosensors
based on results in cell culture [55, 56]. The key regulatory
mechanism in cell culture is the attachment of cells to their
basal substratum via Integrins [49, 67, 68, 78], whose ‘outside-
in’ signalling is firmly implicated inmechanosensation [79–91]
(Fig. 4). In addition, apical signals from Crumbs-Hippo-Warts
may be reduced upon stretching of the apical Spectrin
cytoskeleton [24] while adherens junction or Integrin signals
via Zyxin-Ajuba-Vinculin-Src-FAK may be increased due to
the actomyosin contractile response to tension or stretch
[60, 92], which then induces clustering and activation of
E-cadherin or Integrins and thus Src and FAK to drive YAP/
TAZ to the nucleus [93–105] (Fig. 4). Importantly, there is not
yet conclusive evidence that YAP or TAZ (unlike Yorkie) can
respond to mechanical force in vivo. Since YAP and TAZ
promote normal cell proliferation in the skin, it may be that
Figure 4. Models of mechano-sensing that may control YAP local-
isation. A: Columnar epithelial cells exhibit cytoplasmic YAP at high
density, but nuclear YAP at low density (which induces spreading
out of cells). B: Model for inhibition of apical Crumbs-Hippo
signalling upon cellular stretching (due to de-clustering of Crumbs
complexes). C: Model for activation of Src at adherens junctions
upon cellular stretching (due to induction of actomyosin contractility
to resist stretching, clustering of adherens junctions, and recruitment
of Ajuba/Zyxin family proteins as well as alpha-actinin and Vinculin).
D: Model for activation of basal Integrin-Src signalling upon cellular
stretching (due to formation of focal adhesions which cluster
Integrins and recruit Ajuba/Zyxin, alpha-actinin and Vinculin).
A. Elbediwy et al. Prospects & Overviews....
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the stretching of the skin during post-natal growth or adult
obesity induce YAP and TAZ activity to enable the skin to grow
to cover the entire surface area of the body. Further work is
necessary to develop mechanical stretching systems for
epithelia to measure the requirement for YAP and TAZ in
stretch-dependent growth in vivo.
YAP/TAZ as damage-sensor in vivo
In the mammalian intestinal epithelium, overexpression of
YAP was found to be sufficient to promote increased stem cell
proliferation [106]. Notably, YAP and TAZ double conditional
knockout mice appear not to affect normal gut homeostasis,
but even YAP single-knockouts reduce the tissue damage-
induced or APC-mutant induced proliferation response of this
tissue [107–110]. Note that there is much controversy over how
APC loss leads to YAP/TAZ nuclear localisation [107–110], and
that YAP can in fact remain cytoplasmic in human or mouse
adenomas that retain an apical domain and normal columnar
organisation [49]. Importantly, both tissue damage and APC
loss lead to a strong increase in YAP levels, whichmay include
increased transcription of YAP as well as stabilisation of the
YAP protein [107, 108]. Mechanistically, cytokine receptor
signalling, particularly the gp130 co-receptor, has been
implicated in activating Src family kinases and YAP in the
mouse intestine in response to mucosal injury to promote
proliferative wound healing in the mouse gut [111]. Indepen-
dent work confirms a key role for Src kinase in mouse
intestinal proliferation and tumour formation [54]. Whether
cytokine receptors are the sole signal regulating Src and/or
YAP/TAZ in damaged tissues remains to be clarified.
In the mammalian skin epithelium, overexpression of YAP
is also sufficient to promote increased basal layer prolifera-
tion [76, 77, 112]. Double conditional knockouts for YAP and
TAZ reduce skin proliferation and also reduce the ability of
skin wounds to heal [49]. As in the gut, damage-induced
upregulation of YAP and TAZ can be observed around the
wound site, suggesting that these factorsmay directly respond
to tissue damage to promote the proliferative response [49].
The elevation of YAP/TAZ levels in response to skin damage
requires Src family kinase signalling, although the signals
acting upstream of Src remain unclear [49]. It will also be
interesting to test whether YAP and TAZ contribute to the
inflammatory response that often accompanies different types
of tissue damage.
In the mammalian liver, overexpression of YAP, or loss
of upstream components of the Hippo pathway such as
Merlin/Sav, MST1/2, or Mob1a/1b drive tissue overgrowth
[69, 113–117]. YAP knockout livers are relatively normal sized
but lose some hepatocytes and biliary cells [113]. It will be
interesting to see whether the YAP/TAZ double knockout
livers are also normally sized, andwhether they have difficulty
in regenerating after partial hepatectomy [118, 119].
YAP/TAZ in human epithelial cancers
Most human cancers are epithelial in origin and progression
towards malignant carcinoma involves a disruption of apical-
basalpolarisation, invasivemigrationanddamage/inflammation.
All three of these malignant changes would be expected to
induce YAP/TAZ nuclear localisation. Loss of the apical
domain would be predicted to disrupt Crumbs-Hippo signal-
ling to activate YAP/TAZ [49, 66, 68]. Increased contact with
the extracellular matrix would be predicted to increase
Integrin-Src signalling to activate YAP/TAZ [49, 67, 68].
Invasive migration involves force-generation that may further
activate Integrin-Src signalling and YAP/TAZ [49, 67, 68].
Damage and/or inflammatory responsesmayalso contribute to
stimulation of YAP/TAZ activity in cancer [49, 54, 68, 111].
Notably, these responses may not be limited only to the
proliferating cancer cells themselves but also occur in the
cancer-associated fibroblasts that promote tumour inva-
sion [78]. Thus, YAP/TAZmay be themissing link that explains
why cancers appear to behave as ‘the wound that never heals’,
why inflammation promotes malignancy or why disruption of
epithelial polarity and morphology is such a universal and
predictive hallmark of malignant carcinomas.
Are other functions proposed for YAP/TAZ in
vitro operative in vivo?
Since the localisation and activity of YAP and TAZ can be
readily examined in cell culture, a veritable myriad of
interventions have been proposed to affect their activity in
these assays. For the most part, there is no evidence that any
of these cell culture discoveries actually reflect a physiologi-
cally relevant mechanism of YAP/TAZ regulation in vivo. Here
we focus on just a few examples.
Does Wnt signalling activate YAP/TAZ, or vice versa, in vivo?
YAP/TAZwas reported to inhibitWnt signalling via interactions
between YAP/TAZ and either beta-catenin [120], dishevelled
[121], or the axin/beta-TrCP destruction complex [109]. These
reports predict that loss of YAP/TAZ should result in activation
ofWnt-beta-catenin signalling in vivo, and this does not appear
to be the case in the YAP/TAZ double knockout mouse
intestine [108, 109] or in Drosophila yorkie or mask mutants
or RNAi [6, 10, 29]. Furthermore, these reports also predict that
overexpression of YAP or Yorkie should inhibit Wnt-beta-
catenin signalling invivo, andonce again there isnoconvincing
evidence for this effect in mice or flies [6, 10, 29].
More plausible is the notion that YAP/TAZ-TEAD and beta-
catenin-TCF complexes may cooperate, or antagonise, on the
promoters of particular target genes [122, 123]. Promoters are
indeed where most cross-talk between signalling pathways to
the nucleus takes place in multicellular organisms, because
this mechanism allows for the combinatorial regulation of
gene expressionnecessary formulticellular development [124].
It is also plausible that Wnt-beta-catenin signalling may
simply transcriptionally induce YAP in certain tissues such as
the intestinal crypt.
Amore recent report proposed thatWnt signalling activates
YAP/TAZ via the non-canonical ‘alternative’ Wnt-Frizzled
pathway [125]. The Frizzled receptor family is conserved
between Drosophila and mammals, yet in Drosophila loss of
Frizzled signalling causes defects in planar cell polarity and/or
....Prospects & Overviews A. Elbediwy et al.
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beta-catenin activation but not widespread tissue undergrowth
or loss of Yorkie activity [126, 127]. Instead, it seems that strong
activationofFrizzled incell culturecanartefactually induceRho
GTPase activation and acto-myosin contractility, which then
indirectly activates YAP/TAZ, possibly via mechanical force
effects [125]. Analysis of Frizzled knockout mice is necessary
to determine whether YAP/TAZ activation is physiologically
involved in Frizzled signalling in mammals.
Does BMP/Smad signalling activate YAP/TAZ, or vice versa,
in vivo?
YAP was initially reported to bind to the inhibitory Smad7 to
antagonise Smad3/4 signalling [128]. Later work proposed that
YAP cooperates with Smad1 in nuclear transcription [129] and
that TAZ promotes nuclear localisation and transcriptional
activity of Smad2/3-4 complexes [130]. Next, YAP/TAZ was
proposed to bind to Smad2/3 to retain them in the cytoplasm in
cells cultured at high density, such that both signal transducers
become nuclear at low density [131]. This latter work was
challenged by a recent report that cell density regulates Smad
activation via its effects on the subcellular localisation of
TGF-beta/BMP receptors, rather than via YAP/TAZ [132], and
forced a response from the first group [133]. An independent
group reported that the interaction of YAP/TAZ with Smad2/3
was cell-type specific [134].Notably, theBMP/Smad (Drosophila
Dpp/Mad) pathway is conserved in Drosophila but genetic
analysis has revealed no evidence of direct crosstalk with
Hippo-Yorkie signalling (although theremay be indirect effects
via Ds-Ft-Fj gradients) [34]. Further work is necessary to
test whether the TGFbeta/Smad2 (Drosophila Activin/Smad2)
pathway might affect Yorkie in Drosophila [135]. It will also
be interesting to genetically test whether crosstalk between
YAP/TAZ and Smad signalling operates in mouse tissues.
Does GPCR signalling activate YAP/TAZ in vivo?
The G-protein-coupled receptor (GPCR) agonist ligands
lysophosphatidic acid (LPA) and sphingosine 1-phosphate
(S1P) were reported to activate YAP/TAZ via the G12/13 or Gq/11
protein in cell culture, which activates Rho GTPase to alter
actomyosin contractility [136–138]. Other GPCR agonist
ligands glucagon and epinephrine were found to inhibit
YAP/TAZ activity via GS, cAMP and protein kinase A
(PKA) [136, 139]. Whether any of these signals physiologically
regulate YAP/TAZ in vivo remains unclear. The only
apparently supporting evidence from Drosophila is that pka
mutant tissue overproliferates (though this may be due to
ectopic Hedgehog signalling), while overexpression of PKA
causes apoptosis [139]. On the contrary, the effect of pka
silencing by RNAi on Yorkie target genes cyclinE or expanded
is very mild [139]. Further work is needed to clarify whether
GPCRs or PKA are truly physiologically involved in regulation
of Yorkie or YAP/TAZ in vivo.
Does the Mevalonate pathway activate YAP/TAZ in vivo?
Two reports suggested that YAP/TAZ nuclear localisation
was dependent on the SREBP/Mevalonate pathway, which
turns acetyl-CoA via mevalonate into lipid precursors such as
Farnesyl-PP (a cholesterol and other sterol precursor) and
GeranylGeranyl-PP (a precursor for prenylation of proteins
such as small GTPases) [140, 141]. The proposed mechanism
was that inhibition of mevalonate biosynthesis by Statins
(which inhibit HMG-CoA reductase) impairs prenylation of the
Rho GTPase. However, patients taking Statin drugs do not
report massive side effects on stem cell proliferation and tissue
homeostasis, nor are Statins known to have potent anti-cancer
effects in many solid tumour types, suggesting that Statins
cannot completely inhibit the action of YAP and TAZ in vivo.
In addition, the SREBP/Mevalonate pathway is conserved in
Drosophila but appears to specifically affect lipid synthesis
and cell growth rather than produce Yorkie-like proliferation
phenotypes [142, 143]. Finally, there is no evidence that
regulation of Rho GTPase prenylation is a physiological
mechanism of YAP/TAZ regulation in vivo.
Do growth factors such as EGF receptor ligands or other RTK
ligands activate YAP/TAZ in vivo?
The receptor tyrosine kinase (RTK) family of plasma
membrane receptors is defined by a variable extracellular
domain and a common intracellular tyrosine kinase domain
and includes EGFRs, InsulinR, IGF1R, PDGFRs, CSF1R, Kit,
Flk2, FGFRs, TrkA/B/C, AXL, Ret, ALK, DDR1/2, Ros and Eph
receptors. Binding of ligands such as EGF to the EGFR leads
to Tyrosine Kinase activation and trans-phosphorylation,
which then recruits signal transducers to the multiple
phospho-Tyrosine motifs in the intracellular domain. The
most commonly activated signal transduction pathways
downstream of RTK activation include Ras-MAPK, Src family
kinase, PI3K-Akt-TOR, PLCgamma, and Vav signalling – with
different RTKs activating specific subsets of these pathways.
In cell culture, it was reported that addition of EGF to cells was
able to induce nuclear localisation of YAP/TAZ in a PI3K-
dependent fashion [67, 144]. Results in Drosophila support the
notion that PI3K signalling can activate Yorkie [145]. There is
also a requirement for minimal TOR activation to maintain
Yorkie activity in Drosophila [146]. In mice, there is a good
correlation between EGF ligand and receptor expression and
YAP/TAZ nuclear localisation in skin [49], and EGF ligands
such as amphiregulin (AREG) are also transcriptional targets
of YAP/TAZ in several tissues, forming a possible positive
feedback loop in vivo [74, 110, 147, 148]. Overall, these
promising results support the notion that certain forms of RTK
signalling might physiologically regulate YAP/TAZ activity in
vivo. Further work in vertebrate models will be necessary to
establishwhich RTKs are genetically required to regulate YAP/
TAZ in different tissues, and how RTKs might cross-talk with
Integrin-Src or E-cadherin-Src signals in vivo.
Conclusions
Results from Drosophila and mouse genetics firmly establish
the Yorkie/YAP/TAZ family as a sensor of cell polarity,
mechanical forces and tissue damage in vivo. These three
inputs are frequently misregulated in cancer, providing a
possible explanation for the frequent nuclear localisation
of YAP/TAZ in malignant tumour cells, where YAP/TAZ
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appear to contribute to malignant behaviour. Future work
will need to examine the mechanism by which YAP/TAZ
can respond to these physiological signals in both normal
tissues and cancers. Although other signals have been
proposed to regulate YAP/TAZ in cultured cells, it remains
unclear whether any of these alternative signals are truly of
physiological relevance in both flies and mice. Perhaps the
most promising of the newly proposed signals are the RTKs,
although which of these receptors is necessary to regulate
YAP/TAZ in mouse tissues or tumours requires further genetic
analysis. Overall, the prospects remain bright for a crucial
role for YAP/TAZ signalling in both normal tissue homeostasis
and cancer, making this pathway an attractive biomarker and
target for therapy.
The authors have declared no conflicts of interest.
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